SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-074230
Filing Date
2020-06-17
Accepted
2020-06-17 17:16:58
Documents
4
Period of Report
2020-06-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022699d2_8k.htm 8-K 26047
2 EXHIBIT 1.1 tm2022699d2_ex1-1.htm EX-1.1 215136
3 EXHIBIT 5.1 tm2022699d2_ex5-1.htm EX-5.1 10894
4 GRAPHIC image_001.jpg GRAPHIC 4523
  Complete submission text file 0001104659-20-074230.txt   259745
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 20970533
SIC: 2834 Pharmaceutical Preparations